Zanec

About Zanec

CyberLiver is a late clinical-stage prescription digital therapeutics platform for managing and treating advanced liver diseases. We are a pioneer in discovering, developing, and delivering clinically validated software-based therapeutics to provide better outcomes for patients, smarter engagement, tracking, and management tools for clinicians which are cost-effective and scalable. We lead the fight against advanced liver disease with prescription digital therapies. Two of our products have completed phase 2 equivalent clinical trials, third in the discovery phase: 1. AlcoChange - for the treatment of alcohol-related liver disease (ARLD) patients 2. CirrhoCare - for remote monitoring and treatment of decompensated cirrhosis patients